# Clinical Performance of the AtbFinder® Test System for Selection of Antibiotic Therapy in Persons With Cystic Fibrosis

> **NCT05584982** · NA · COMPLETED · sponsor: **TGV-Dx** · enrollment: 35 (actual)

## Conditions studied

- Cystic Fibrosis
- Lung Infection Bacterial

## Interventions

- **DEVICE:** AtbFinder

## Key facts

- **NCT ID:** NCT05584982
- **Lead sponsor:** TGV-Dx
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2022-10-12
- **Final completion:** 2022-10-12
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2022-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05584982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05584982, "Clinical Performance of the AtbFinder® Test System for Selection of Antibiotic Therapy in Persons With Cystic Fibrosis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05584982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*